Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI.

Evans A, Whelehan P, Thompson A, Purdie C, Jordan L, Macaskill J, Henderson S, Vinnicombe S.

Clin Radiol. 2018 Jul 3. pii: S0009-9260(18)30223-X. doi: 10.1016/j.crad.2018.05.030. [Epub ahead of print]

PMID:
29980324
2.

Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival.

Evans A, Sim YT, Pourreyron C, Thompson A, Jordan L, Fleming D, Purdie C, Macaskill J, Vinnicombe S, Pharoah P.

Breast Cancer Res Treat. 2018 Jun 1. doi: 10.1007/s10549-018-4836-5. [Epub ahead of print]

PMID:
29858751
3.

Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy.

Henderson SA, Muhammad Gowdh N, Purdie CA, Jordan LB, Evans A, Brunton T, Thompson AM, Vinnicombe S.

Br J Radiol. 2018 Jul;91(1087):20180123. doi: 10.1259/bjr.20180123. Epub 2018 May 2.

PMID:
29641224
4.

Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers.

Glodzik D, Morganella S, Davies H, Simpson PT, Li Y, Zou X, Diez-Perez J, Staaf J, Alexandrov LB, Smid M, Brinkman AB, Rye IH, Russnes H, Raine K, Purdie CA, Lakhani SR, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Viari A, Easton D, Evan G, Campbell PJ, Stratton MR, Nik-Zainal S.

Nat Genet. 2017 Oct 27;49(11):1661. doi: 10.1038/ng1117-1661a.

PMID:
29074948
5.

Correlation of X-ray diffraction signatures of breast tissue and their histopathological classification.

Moss RM, Amin AS, Crews C, Purdie CA, Jordan LB, Iacoviello F, Evans A, Speller RD, Vinnicombe SJ.

Sci Rep. 2017 Oct 11;7(1):12998. doi: 10.1038/s41598-017-13399-9.

6.

Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI.

Evans A, Whelehan P, Thompson A, Purdie C, Jordan L, Macaskill J, Waugh S, Fuller-Pace F, Brauer K, Vinnicombe S.

Ultraschall Med. 2017 Sep 21. doi: 10.1055/s-0043-111589. [Epub ahead of print]

PMID:
28934812
7.

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency.

Davies H, Morganella S, Purdie CA, Jang SJ, Borgen E, Russnes H, Glodzik D, Zou X, Viari A, Richardson AL, Børresen-Dale AL, Thompson A, Eyfjord JE, Kong G, Stratton MR, Nik-Zainal S.

Cancer Res. 2017 Sep 15;77(18):4755-4762. doi: 10.1158/0008-5472.CAN-17-1083.

PMID:
28904067
8.

PROMsBase: Web-based repository portal for patient-reported outcome measures in orthopaedics.

Tirosh O, Tran P, Renouf J, Pergaminelis N, Purdie CN, Ho A, Gibbens A.

Health Informatics J. 2017 Aug 1:1460458217725904. doi: 10.1177/1460458217725904. [Epub ahead of print]

PMID:
28841810
9.

Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.

Henderson S, Purdie C, Michie C, Evans A, Lerski R, Johnston M, Vinnicombe S, Thompson AM.

Eur Radiol. 2017 Nov;27(11):4602-4611. doi: 10.1007/s00330-017-4850-8. Epub 2017 May 18.

10.

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.

Ju YS, Martincorena I, Gerstung M, Petljak M, Alexandrov LB, Rahbari R, Wedge DC, Davies HR, Ramakrishna M, Fullam A, Martin S, Alder C, Patel N, Gamble S, O'Meara S, Giri DD, Sauer T, Pinder SE, Purdie CA, Borg Å, Stunnenberg H, van de Vijver M, Tan BK, Caldas C, Tutt A, Ueno NT, van 't Veer LJ, Martens JW, Sotiriou C, Knappskog S, Span PN, Lakhani SR, Eyfjörd JE, Børresen-Dale AL, Richardson A, Thompson AM, Viari A, Hurles ME, Nik-Zainal S, Campbell PJ, Stratton MR.

Nature. 2017 Mar 30;543(7647):714-718. doi: 10.1038/nature21703. Epub 2017 Mar 22.

PMID:
28329761
11.

A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers.

Glodzik D, Morganella S, Davies H, Simpson PT, Li Y, Zou X, Diez-Perez J, Staaf J, Alexandrov LB, Smid M, Brinkman AB, Rye IH, Russnes H, Raine K, Purdie CA, Lakhani SR, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Viari A, Easton D, Evan G, Campbell PJ, Stratton MR, Nik-Zainal S.

Nat Genet. 2017 Mar;49(3):341-348. doi: 10.1038/ng.3771. Epub 2017 Jan 23. Erratum in: Nat Genet. 2017 Oct 27;49(11):1661.

12.

TP53 drives invasion through expression of its Δ133p53β variant.

Gadea G, Arsic N, Fernandes K, Diot A, Joruiz SM, Abdallah S, Meuray V, Vinot S, Anguille C, Remenyi J, Khoury MP, Quinlan PR, Purdie CA, Jordan LB, Fuller-Pace FV, de Toledo M, Cren M, Thompson AM, Bourdon JC, Roux P.

Elife. 2016 Sep 15;5. pii: e14734. doi: 10.7554/eLife.14734.

13.

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.

Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van der Smissen WJ, Vlugt-Daane MV, van Galen A, Nik-Zainal S, Staaf J, Brinkman AB, van de Vijver MJ, Richardson AL, Fatima A, Berentsen K, Butler A, Martin S, Davies HR, Debets R, Gelder ME, van Deurzen CH, MacGrogan G, Van den Eynden GG, Purdie C, Thompson AM, Caldas C, Span PN, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Ringnér M, Tommasi S, Eyford J, Broeks A, Vincent-Salomon A, Futreal PA, Knappskog S, King T, Thomas G, Viari A, Langerød A, Børresen-Dale AL, Birney E, Stunnenberg HG, Stratton M, Foekens JA, Martens JW.

Nat Commun. 2016 Sep 26;7:12910. doi: 10.1038/ncomms12910.

14.

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.

Hadad SM, Jordan LB, Roy PG, Purdie CA, Iwamoto T, Pusztai L, Moulder-Thompson SL, Thompson AM.

BMC Cancer. 2016 Sep 22;16(1):745.

15.

Stiffness at shear-wave elastography and patient presentation predicts upgrade at surgery following an ultrasound-guided core biopsy diagnosis of ductal carcinoma in situ.

Evans A, Purdie CA, Jordan L, Macaskill EJ, Flynn J, Vinnicombe S.

Clin Radiol. 2016 Nov;71(11):1156-9. doi: 10.1016/j.crad.2016.07.004. Epub 2016 Aug 5.

PMID:
27499466
16.

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M; ICGC Prostate Cancer Working Group; ICGC Bone Cancer Working Group; ICGC Breast Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, Van't Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova GS, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR.

Genome Res. 2016 May;26(5):717.2. doi: 10.1101/gr.206557.116. No abstract available.

17.

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, van't Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR.

Nature. 2016 Jun 2;534(7605):47-54. doi: 10.1038/nature17676. Epub 2016 May 2.

18.

Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right.

Francis A, Bartlett J, Rea D, Pinder SE, Stein RC, Stobart H, Purdie CA, Rakha E, Thompson A, Shaaban AM; Translational Subgroup of the NCRI Breast Clinical Studies Group.

Eur J Surg Oncol. 2016 Jul;42(7):994-8. doi: 10.1016/j.ejso.2016.02.015. Epub 2016 Mar 16.

PMID:
27020141
19.

Shear wave elastography of breast cancer: Sensitivity according to histological type in a large cohort.

Evans A, Sim YT, Thomson K, Jordan L, Purdie C, Vinnicombe SJ.

Breast. 2016 Apr;26:115-8. doi: 10.1016/j.breast.2016.01.009. Epub 2016 Feb 18.

PMID:
27017250
20.

Shear-wave elastography and greyscale assessment of palpable probably benign masses: is biopsy always required?

Giannotti E, Vinnicombe S, Thomson K, McLean D, Purdie C, Jordan L, Evans A.

Br J Radiol. 2016 Jun;89(1062):20150865. doi: 10.1259/bjr.20150865. Epub 2016 Mar 23.

21.

The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network.

Quinlan PR, Groves M, Jordan LB, Stobart H, Purdie CA, Thompson AM.

Biopreserv Biobank. 2015 Oct;13(5):363-70. doi: 10.1089/bio.2014.0099. Epub 2015 Sep 29.

22.

Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.

Akbar S, Jordan LB, Purdie CA, Thompson AM, McKenna SJ.

Br J Cancer. 2015 Sep 29;113(7):1075-80. doi: 10.1038/bjc.2015.309. Epub 2015 Sep 8.

23.

Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer.

Lin ML, Patel H, Remenyi J, Banerji CR, Lai CF, Periyasamy M, Lombardo Y, Busonero C, Ottaviani S, Passey A, Quinlan PR, Purdie CA, Jordan LB, Thompson AM, Finn RS, Rueda OM, Caldas C, Gil J, Coombes RC, Fuller-Pace FV, Teschendorff AE, Buluwela L, Ali S.

Oncotarget. 2015 Aug 28;6(25):21685-703.

24.

Magnetic resonance imaging texture analysis classification of primary breast cancer.

Waugh SA, Purdie CA, Jordan LB, Vinnicombe S, Lerski RA, Martin P, Thompson AM.

Eur Radiol. 2016 Feb;26(2):322-30. doi: 10.1007/s00330-015-3845-6. Epub 2015 Jun 12.

PMID:
26065395
25.

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study.

Hyde N, Dodd S, Venugopal K, Purdie C, Berk M, O'Neil A.

Curr Drug Saf. 2015;10(2):125-31.

PMID:
25986036
26.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M; ICGC Prostate Cancer Working Group; ICGC Bone Cancer Working Group; ICGC Breast Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, van't Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova SG, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR.

Genome Res. 2015 Jun;25(6):814-24. doi: 10.1101/gr.190470.115. Epub 2015 May 11. Erratum in: Genome Res. 2016 May;26(5):717.2.

27.

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial.

Hadad SM, Coates P, Jordan LB, Dowling RJ, Chang MC, Done SJ, Purdie CA, Goodwin PJ, Stambolic V, Moulder-Thompson S, Thompson AM.

Breast Cancer Res Treat. 2015 Feb;150(1):149-55. doi: 10.1007/s10549-015-3307-5. Epub 2015 Feb 15.

PMID:
25682077
28.

Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.

Pinder SE, Rakha EA, Purdie CA, Bartlett JM, Francis A, Stein RC, Thompson AM, Shaaban AM; Translational Subgroup of the NCRI Breast Clinical Studies Group.

Histopathology. 2015 Sep;67(3):279-93. doi: 10.1111/his.12649. Epub 2015 Mar 8. Review.

PMID:
25585651
29.

Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.

Bouchalova P, Nenutil R, Muller P, Hrstka R, Appleyard MV, Murray K, Jordan LB, Purdie CA, Quinlan P, Thompson AM, Vojtesek B, Coates PJ.

J Pathol. 2014 Jul;233(3):238-46. doi: 10.1002/path.4356. Epub 2014 May 21.

PMID:
24687952
30.

What are the characteristics of breast cancers misclassified as benign by quantitative ultrasound shear wave elastography?

Vinnicombe SJ, Whelehan P, Thomson K, McLean D, Purdie CA, Jordan LB, Hubbard S, Evans AJ.

Eur Radiol. 2014 Apr;24(4):921-6. doi: 10.1007/s00330-013-3079-4. Epub 2013 Dec 11.

PMID:
24326756
31.

Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?

Evans A, Rauchhaus P, Whelehan P, Thomson K, Purdie CA, Jordan LB, Michie CO, Thompson A, Vinnicombe S.

Breast Cancer Res Treat. 2014 Jan;143(1):153-7. doi: 10.1007/s10549-013-2747-z. Epub 2013 Dec 4.

32.

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.

Purdie CA, Quinlan P, Jordan LB, Ashfield A, Ogston S, Dewar JA, Thompson AM.

Br J Cancer. 2014 Feb 4;110(3):565-72. doi: 10.1038/bjc.2013.756. Epub 2013 Dec 3.

33.

Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?

Evans A, Armstrong S, Whelehan P, Thomson K, Rauchhaus P, Purdie C, Jordan L, Jones L, Thompson A, Vinnicombe S.

Br J Cancer. 2013 Nov 26;109(11):2798-802. doi: 10.1038/bjc.2013.660. Epub 2013 Oct 29.

34.

HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice.

Shaaban AM, Purdie CA, Bartlett JM, Stein RC, Lane S, Francis A, Thompson AM, Pinder SE; Translational Subgroup of the NCRI Breast Clinical Studies Group.

J Clin Pathol. 2014 Feb;67(2):161-7. doi: 10.1136/jclinpath-2013-201819. Epub 2013 Sep 23.

PMID:
24062360
35.

CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.

Province MA, Goetz MP, Brauch H, Flockhart DA, Hebert JM, Whaley R, Suman VJ, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman WG, Lee MT, Ambrosone CB, Beckmann MW, Choi JY, Dieudonné AS, Fasching PA, Ferraldeschi R, Gong L, Haschke-Becher E, Howell A, Jordan LB, Hamann U, Kiyotani K, Krippl P, Lambrechts D, Latif A, Langsenlehner U, Lorizio W, Neven P, Nguyen AT, Park BW, Purdie CA, Quinlan P, Renner W, Schmidt M, Schwab M, Shin JG, Stingl JC, Wegman P, Wingren S, Wu AH, Ziv E, Zirpoli G, Thompson AM, Jordan VC, Nakamura Y, Altman RB, Ames MM, Weinshilboum RM, Eichelbaum M, Ingle JN, Klein TE; International Tamoxifen Pharmacogenomics Consortium.

Clin Pharmacol Ther. 2014 Feb;95(2):216-27. doi: 10.1038/clpt.2013.186. Epub 2013 Sep 23.

36.

Clinical value of internal mammary lymph node metastases found incidentally during free flap recipient vessel exposure.

Schaverien MV, Purdie CA, Munnoch DA.

Eur J Surg Oncol. 2013 Jun;39(6):608-12. doi: 10.1016/j.ejso.2013.03.009. Epub 2013 Apr 4.

PMID:
23562362
37.

Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis?

Mullen R, Purdie CA, Jordan LB, McLean D, Whelehan P, Vinnicombe S, Brown DC, Evans A.

Clin Radiol. 2013 Jul;68(7):704-7. doi: 10.1016/j.crad.2013.01.020. Epub 2013 Mar 19.

PMID:
23518495
38.

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer.

Dayal JH, Sales MJ, Corver WE, Purdie CA, Jordan LB, Quinlan PR, Baker L, ter Haar NT, Pratt NR, Thompson AM.

Br J Cancer. 2013 Mar 5;108(4):873-80. doi: 10.1038/bjc.2013.42. Epub 2013 Feb 14.

39.

Giant pendulous fibroma of the breast associated with a locally advanced carcinoma of the breast.

Mullen R, Reiss MM, Fleming D, Evans A, Purdie CA.

Breast J. 2012 Nov-Dec;18(6):602-3. doi: 10.1111/tbj.12038. Epub 2012 Oct 30. No abstract available.

PMID:
23110449
40.

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.

Pinder SE, Brown JP, Gillett C, Purdie CA, Speirs V, Thompson AM, Shaaban AM; Translational Subgroup of the NCRI Breast Clinical Studies Group.

J Clin Pathol. 2013 Mar;66(3):169-77. doi: 10.1136/jclinpath-2012-201091. Epub 2012 Oct 19. Review.

PMID:
23087330
41.

Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification.

Evans A, Whelehan P, Thomson K, Brauer K, Jordan L, Purdie C, McLean D, Baker L, Vinnicombe S, Thompson A.

Br J Cancer. 2012 Jul 10;107(2):224-9. doi: 10.1038/bjc.2012.253. Epub 2012 Jun 12.

42.

Sentinel node biopsy in breast cancer has a greater node positivity rate than axillary node sample: results from a retrospective analysis.

Macaskill EJ, Dewar S, Purdie CA, Brauer K, Baker L, Brown DC.

Eur J Surg Oncol. 2012 Aug;38(8):662-9. doi: 10.1016/j.ejso.2012.04.006. Epub 2012 May 15.

PMID:
22592099
43.

Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors.

Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, Baker L, Jordan L, Rauchhaus P, Thompson A.

Radiology. 2012 Jun;263(3):673-7. doi: 10.1148/radiol.12111317. Epub 2012 Apr 20.

PMID:
22523322
44.

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom.

King SI, Purdie CA, Bray SE, Quinlan PR, Jordan LB, Thompson AM, Meek DW.

Breast Cancer Res. 2012 Mar 8;14(2):R40.

45.

Involved anterior margins after breast conserving surgery: is re-excision required?

Mullen R, Macaskill EJ, Khalil A, Elseedawy E, Brown DC, Lee AC, Purdie CA, Jordan LB, Thompson AM.

Eur J Surg Oncol. 2012 Apr;38(4):302-6. doi: 10.1016/j.ejso.2012.01.004. Epub 2012 Jan 27.

PMID:
22285907
46.

Biomarker discordance: prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility.

Moussa O, Purdie C, Vinnicombe S, Thompson AM.

Cancer Biomark. 2012-2013;12(6):231-9. doi: 10.3233/CBM-130314. Review.

PMID:
23735943
47.

High frequency of complex TP53 mutations in CNS metastases from breast cancer.

Lo Nigro C, Vivenza D, Monteverde M, Lattanzio L, Gojis O, Garrone O, Comino A, Merlano M, Quinlan PR, Syed N, Purdie CA, Thompson A, Palmieri C, Crook T.

Br J Cancer. 2012 Jan 17;106(2):397-404. doi: 10.1038/bjc.2011.464. Epub 2011 Dec 20.

48.

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, Coleman RE, Freedman OC, Jordan LB, Thompson AM.

Cancer Treat Rev. 2012 Oct;38(6):708-14. doi: 10.1016/j.ctrv.2011.11.006. Epub 2011 Dec 16.

PMID:
22178456
49.

Axillary lymph node core biopsy for breast cancer metastases -- how many needle passes are enough?

Macaskill EJ, Purdie CA, Jordan LB, Mclean D, Whelehan P, Brown DC, Evans A.

Clin Radiol. 2012 May;67(5):417-9. doi: 10.1016/j.crad.2011.10.006. Epub 2011 Nov 26.

PMID:
22119100
50.

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

Hadad S, Iwamoto T, Jordan L, Purdie C, Bray S, Baker L, Jellema G, Deharo S, Hardie DG, Pusztai L, Moulder-Thompson S, Dewar JA, Thompson AM.

Breast Cancer Res Treat. 2011 Aug;128(3):783-94. doi: 10.1007/s10549-011-1612-1. Epub 2011 Jun 8.

PMID:
21655990

Supplemental Content

Loading ...
Support Center